Sort
46,585 grants matching “heart failure”
Mesenchymal stem cell therapy for endothelial dysfunction in diabetes
$649,405Ivonne H Schulman · University Of Miami School Of Medicine · R01 · FY2016 · HL
Multivalent Toxoid Vaccine for recurrent Staphylococccus aureus disease
$649,379M. Javad Aman · Abvacc, Inc. · R01 · FY2024 · AI
Targeting the Arrhythmogenic Sources of Human Atrial Fibrillation
$649,348Vadim V Fedorov · Ohio State University · R01 · FY2024 · HL
1/2 Alcohol Associated Comorbidities and Microbiome Evaluation in HIV (ACME HIV)
$649,329Matthew S Freiberg · Vanderbilt University Medical Center · U01 · FY2019 · AA
A nationwide population-based study investigating the cardiovascular effects of exposure to particulate matter α-, β-, and γ-activities and individual radionuclides
$649,282Antonella Zanobetti · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2025 · ES
Digoxin Pharmacodynamics in Infants with Heart Failure due to Single Ventricle Congenital Heart Disease
$649,188Christoph Hornik · Duke University · R01 · FY2022 · HD
Bioengineering of Transplantable Humanized Lungs from iPS Cells
$649,164Darrell N. Kotton · Boston University Medical Campus · R01 · FY2012 · HL
Ultrasound clutter and noise improvements applied to echocardiographic left atrial appendage visualization
$649,155Brett C Byram · Vanderbilt University · R01 · FY2021 · HL
Pathophysiological Regulation of Cardiac Myocyte RyR Channel
$649,140Donald M Bers · University Of California At Davis · R01 · FY2017 · HL
Pathophysiological Regulation of Cardiac Myocyte RyR Channel
$649,140Donald M Bers · University Of California At Davis · R01 · FY2016 · HL
Kidney Tubular Damage and Dysfunction in Autosomal Dominant Polycystic Kidney Disease
$649,120Pranav Garimella · University Of California, San Diego · R01 · FY2024 · DK
A Phase II Trial of Metformin for Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction
$649,113Marc A Simon · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · AG
Functional and mechanistic delineation of HuR-Wisp1 signaling on myofibroblast activity
$649,059Michael Tranter · Ohio State University · R01 · FY2025 · HL
Improve the Meaning of Patient Reported Outcomes to Evaluate Effectiveness for Cardiac Care" (IMPROVE-Cardiac Care)
$648,944Ruth Marie Masterson Creber · Columbia University Health Sciences · R01 · FY2023 · HL
Improving outcomes from cardiac rehabilitation among older adults through exercise testing and individualized exercise intensity prescriptions
$648,940Quinn Russell Pack · Baystate Medical Center, Inc. · R01 · FY2022 · AG
Regulation of Cardiac Collagen Content by SLIT3
$648,862Ming-Sing Si · University Of California Los Angeles · R01 · FY2022 · HL
Anaplerotic reprogramming of endothelial cells in pulmonary hypertension
$648,802Ruslan Rafikov · University Of Arizona · R01 · FY2022 · HL
Mechanisms for Stem Cell Differentiation into Cardiac Myocytes
$648,787Margaret Loewy Kirby · Duke University · R01 · FY2009 · HL
Induction of Cardiomyocyte Proliferation via Transient Expression of Cell Cycle Factors as a Promising Therapy for Heart Failure
$648,772Tamer M A Mohamed · Baylor College Of Medicine · R01 · FY2023 · HL
Developing Machine Learning Models for Decision Support and Allocation Optimization in Heart Transplantation
$648,772Arman Kilic · Medical University Of South Carolina · R01 · FY2025 · HL
The Atrial Fibrillation-Factor Identification to Risk Modification Study in CKD/ESRD
$648,717Wolfgang Christoph Winkelmayer · Baylor College Of Medicine · R01 · FY2020 · DK
Chronic Kidney Disease Prognosis Consortium
$648,576Josef Coresh · Johns Hopkins University · R01 · FY2016 · DK
Non-Invasive Inhaled NO in Premature Newborns
$648,557John P Kinsella · University Of Colorado Denver · P50 · FY2009 · HL
Critical Mediators of Inflammation Resolution and Immune Memory in Atherosclerosis
$648,535Amanda C Doran · Vanderbilt University Medical Center · R01 · FY2022 · HL
Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)
$648,527Wilbur A Lam · Emory University · U54 · FY2022 · EB